The effects of drugs used to treat obesity on the autonomic nervous system

Obesity Research

Volumn 8, Issue 3, 2000, Pages 227-233

  Hirsch, Jules ^a   Mackintosh, Ronald M ^a   Aronne, Louis J ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

Author keywords

Anti obesity drugs; Autonomic nervous system; Dexfenfluramine; Phentermine; Sibutramine

Indexed keywords

ADRENALIN; ANOREXIGENIC AGENT; ATROPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CREATININE; CYCLOBUTANE DERIVATIVE; DEXFENFLURAMINE; DOPAMINE; ESMOLOL; NORADRENALIN; PHENTERMINE; PROPANOLAMINE DERIVATIVE; SEROTONIN AGONIST; SIBUTRAMINE;

ADULT; ARTICLE; AUTONOMIC NERVOUS SYSTEM; BASAL METABOLIC RATE; CALORIMETRY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; HEART RATE; HUMAN; MALE; OBESITY; SINGLE BLIND PROCEDURE; URINE;

ADRENERGIC BETA-ANTAGONISTS; ADULT; APPETITE DEPRESSANTS; ATROPINE; AUTONOMIC NERVOUS SYSTEM; BASAL METABOLISM; CALORIMETRY; CREATININE; CYCLOBUTANES; DEXFENFLURAMINE; DOPAMINE; EPINEPHRINE; HEART RATE; HUMANS; MALE; NOREPINEPHRINE; OBESITY; PARASYMPATHOLYTICS; PHENTERMINE; PROPANOLAMINES; SEROTONIN AGONISTS; SINGLE-BLIND METHOD;

EID: 0034181659     PISSN: 10717323     EISSN: None     Source Type: Journal    
DOI: 10.1038/oby.2000.26     Document Type: Article

References (14)

1. Rosenbaum M, Leibel RL, Hirsch J. Obesity. N Engl J Med. 1997;337:396-407.
2. Silverstone T. Appetite suppressants. Drugs. 1992;43:820-6.
3. Stock MJ. Sibutramine: a review of the pharmacology of a novel anti-obesity agent. Int J Obes. 1997(Suppl 1); 21:S25-29.
4. Anderson B, Zimmermann ME, Hedner T, Bjorntorp P. Hemodynamic, metabolic and endocrine effects of short-term dexfenfluramine treatment in young, obese women. Eur J Clin Pharmacol. 1991;40:249-54.
5. McTavish D, Heel RC. Dexfenfluramine. Drugs. 1992;43: 713-33.
6. Aronne LJ, Mackintosh R, Rosenbaum M, Leibel RL, Hirsch J. Autonomic nervous system activities in weight gain and weight loss. Am J Physiol. 1995;269:R222-R5.
7. Aronne LJ, Mackintosh R, Rosenbaum M, Leibel RL, Hirsch J. Cardiac autonomic nervous system activity in obese and never-obese young men. Obes Res. 1997;5:354-9.
8. Harris JA, Benedict FG. A biometric study of basal metabolism in man. Carnegie Inst Wash Bull. 1919;279:40-4.
9. Abenhaim L, Moride Y, Brenot F, et al. Appetite-suppressant drugs and the risk of primary pulmonary hypertension: International Primary Pulmonary Hypertension Study Group. N Engl J Med. 1996;335:609-16.
10. Connolly HM, Crary JL, McGoon MD, et al. Valvular heart disease associated with fenfluramine-phentermine. N Engl J Med. 1997;337:581-8.
11. Linden AS, Desmecht DJ, Amory H, Lekeux PM. Parasympathetic component of 5-hydroxytryptamine-induced pulmonary dysfunctions in healthy calves. Am J Vet Res. 1996;57:896-901.
12. 3H]acetylcholine release in rat cortical synaptosomes. Pharmacol Res. 1997;35:351-4.
13. 3 and 5-HT4 receptor-mediated stimulation of gastric emptying in rats. Arzneim-Forsch. 1997;47:1242-6.
14. Overstreet DH, Daws LC, Schiller GD, Orbach J, Janowsky DS. Cholinergic/serotonergic interactions in hypothermia: implications for rat models of depression. Pharmacol Biochem Behav. 1998;59:777-85.